Validea's Leading Consumer Discretionary Stocks According to Joel Greenblatt - September 14, 2025
Top Rated Consumer Discretionary Stocks: The article highlights top-rated Consumer Discretionary stocks according to Validea's Earnings Yield Investor model, which is based on Joel Greenblatt's strategy focusing on high return on capital and earnings yields.
Company Profiles: It provides detailed descriptions and ratings for several companies, including Bath & Body Works (100% rating), QuantaSing Group (100% rating), Abercrombie & Fitch (90% rating), Best Buy (70% rating), and TopBuild Corp (60% rating), indicating their performance and market positioning.
Investment Strategy: The ratings are based on the companies' underlying fundamentals and stock valuations, with scores above 80% indicating interest and scores above 90% indicating strong interest in the stocks.
About Joel Greenblatt and Validea: The article mentions Joel Greenblatt's successful investment strategy outlined in his book "The Little Book That Beats The Market" and introduces Validea as an investment research service that follows the strategies of renowned investors.
Trade with 70% Backtested Accuracy
Analyst Views on BBWI
About BBWI
About the author

- Class Action Timeline: Investors who purchased Bath & Body Works (NYSE: BBWI) securities between June 4, 2024, and November 19, 2025, should note that the deadline to apply as lead plaintiff is March 16, 2026, and failure to apply may result in loss of compensation rights.
- Lawsuit Background: The lawsuit alleges that the company made materially false statements during this period, failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, leading to investor losses when the truth emerged.
- Legal Counsel Recommendation: Investors are encouraged to select law firms with a proven track record; Rosen Law Firm is recognized for its success in securities class actions and has secured significant settlements, ensuring effective protection of investor rights.
- Participation Instructions: Investors can join the class action by visiting the specified website or calling the toll-free number, and it is crucial to choose appropriate legal counsel as investors are not represented until the class is certified.
- Lawsuit Background: Bath & Body Works, Inc. faces a class action lawsuit for alleged violations of federal securities laws, targeting investors who purchased the company's securities between June 4, 2024, and November 19, 2025, aiming to recover damages.
- False Statements Allegation: The complaint alleges that company executives made materially false and misleading statements during the class period, failing to disclose adverse facts about the company's business and financial outlook, misleading investors.
- Financial Guidance Missteps: The lawsuit highlights that the company's strategy of 'adjacencies, collaborations, and promotions' did not effectively grow the customer base and relied on brand collaborations to mask weak financial results, likely leading to unmet financial guidance.
- Investor Rights Protection: Investors in Bath & Body have until March 13, 2026, to apply as lead plaintiffs, with the law firm representing them on a contingency fee basis, ensuring that investor rights are restored in the process.
- Legal Investigation: Faruq & Faruq LLP is investigating potential claims against Bath & Body Works due to possible false statements made during securities transactions between June 4, 2024, and November 19, 2025, which may have harmed investors' rights.
- Declining Financial Performance: In Q3 2025, Bath & Body Works reported a 1% year-over-year revenue decline, missing its growth guidance of 1-3%, with net income plummeting 26% to $77 million, indicating a failure in the company's strategy.
- Acknowledgment of Strategic Failures: The company admitted during an investor presentation that its focus on “adjacencies, collaborations, and promotions” failed to effectively grow its customer base, leading to reduced investment in core categories and reliance on brand collaborations to mask weak financial results.
- Significant Stock Price Drop: Following the disappointing earnings report, Bath & Body Works' stock price fell by $5.22, or 24.8%, closing at $15.82 per share, reflecting market pessimism regarding the company's future prospects.
- Class Action Timeline: Investors who purchased Bath & Body Works (NYSE: BBWI) securities between June 4, 2024, and November 19, 2025, should note that the deadline to apply as lead plaintiff is March 16, 2026, and failing to act may result in loss of compensation rights.
- Lawsuit Allegations: The lawsuit claims that the company made materially false statements during the class period, failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, leading to investor losses when the truth emerged.
- Law Firm Credentials: The Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first by ISS Securities Class Action Services in 2017, showcasing its expertise and success in this field.
- How to Participate: Investors can join the class action by visiting the Rosen Law Firm's website or calling toll-free at 866-767-3653 to ensure their rights are protected, emphasizing the importance of selecting qualified legal counsel over inexperienced intermediaries.
- Bath & Body Works Lawsuit: Bath & Body Works faces a class action for failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' did not effectively grow its customer base, resulting in a 1% year-over-year revenue decline in Q3 2025, missing the 1-3% growth guidance, and a 26% drop in net income to $77 million, highlighting the company's financial fragility.
- Guidance Downgrade: The company slashed its full-year net sales guidance below expectations and cut earnings per share from $3.28 to at least $2.83, indicating uncertainty in future profitability, which could undermine investor confidence.
- BellRing Brands Lawsuit: BellRing Brands is facing a class action for not disclosing that strong sales results were not due to increased consumer demand but rather excess inventory accumulated by customers due to previous product shortages, leading to a bleak 2025 sales outlook with net sales projected between $2.28 billion and $2.32 billion, reflecting weakening market demand.
- Significant Stock Declines: Following the disappointing financial reports, Bath & Body Works' stock plummeted 24.8% to close at $15.82 per share, while BellRing's stock dropped nearly 33% to $36.18 per share on August 5, 2025, indicating a pessimistic outlook for both companies' future performance.
- Shareholder Notice Issued: The Gross Law Firm has issued a notice to shareholders of Bath & Body Works (NYSE:BBWI), encouraging those who purchased shares between June 4, 2024, and November 9, 2025, to contact the firm regarding potential lead plaintiff status, indicating the company is facing legal challenges.
- Allegations Overview: The lawsuit alleges that during the class period, Bath & Body Works made materially false statements and failed to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, resulting in net sales growth falling short of expectations and impacting financial performance.
- Financial Guidance Missteps: The lawsuit highlights that the company is unlikely to meet its previously issued financial guidance, suggesting that management's positive statements lacked a reasonable basis, which could lead to diminished investor confidence and negatively affect stock performance.
- Registration Deadline: Shareholders must register for the class action by March 13, 2026, and upon registration, they will receive updates on the case's progress, demonstrating the potential impact of legal proceedings on investors.







